Drew J. Winston

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 7 papers. Top paper: “Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection”.

Comparative Emergence of Maribavir and Ganciclovir Resistance in a Randomized Phase 3 Clinical Trial for Treatment of Cytomegalovirus Infection

The Journal of Infectious Diseases(2024)10.1093/infdis/jiae469

N/A

0.999DataRank · unranked

27 citations

Drew J. Winston, Robin K. Avery, Catherine Cordonnier, Rafael F. Duarte, Shariq Haider +8 more

Risk Factors for Cytomegalovirus Viremia following Liver Transplantation With a Seropositive Donor and Seronegative Recipient Receiving Antiviral Therapy

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa470

N/A

0.380DataRank · unranked

5 citations

Drew J. Winston, Raymund R. Razonable, G. Marshall Lyon, Fernanda P. Silveira, Marilyn M. Wagener +2 more

Cytomegalovirus (CMV) Cell-Mediated Immunity and CMV Infection After Allogeneic Hematopoietic Cell Transplantation: The REACT Study

Clinical Infectious Diseases(2020)10.1093/cid/ciz1210

N/A

0DataRank · unranked

111 citations

Lynn El Haddad, Drew J. Winston, Scott D. Rowley, Kathleen M Mulane, Pranatharthi Chandrasekar +13 more

Impact of Baseline and Week 2 and Week 4 Posttransplant CMV Cell-Mediated Immunity on Risk of CMV Infections and Mortality in Recipients of Allogeneic Hematopoietic Cell Transplant

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad386

N/A

0DataRank · unranked

13 citations

Drew J. Winston, Scott D. Rowley, Kathleen M. Mullane, Pranatharthi Chandrasekar, Parameswaran Hari +14 more

Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis

JCI Insight(2024)10.1172/jci.insight.180115

N/A

0DataRank · unranked

8 citations

Sayan Dasgupta, Terry Stevens‐Ayers, Bradley Edmison, Drew J. Winston, Raymund R. Razonable +7 more

Unexpected Cytomegalovirus (CMV) Replication Kinetics in CMV Donor-Seropositive, Recipient-Seronegative Liver Transplant Recipients Receiving Preemptive Antiviral Therapy

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab132

N/A

0DataRank · unranked

11 citations

Drew J. Winston, Raymund R. Razonable, G. Marshall Lyon, Fernanda P. Silveira, Marilyn M. Wagener +2 more

Cost-effectiveness of Preemptive Therapy Versus Prophylaxis in a Randomized Clinical Trial for the Prevention of Cytomegalovirus Disease in Seronegative Liver Transplant Recipients With Seropositive Donors

Clinical Infectious Diseases(2020)10.1093/cid/ciaa1051

N/A

0DataRank · unranked

27 citations

Drew J. Winston, Raymund R. Razonable, G. Marshall Lyon, Fernanda P. Silveira, Marilyn M. Wagener +2 more